Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Leht 1 alates 23 tulemused
Myotonia associated with cancer.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Myotonia in patients treated for cancer with didemnin B.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
[Paraneoplastic neuromuscular manifestations--apropos of a case presenting successively a picture of myotonia, then myasthenia with myositis 4 years before the diagnosis of a colonic neoplasm].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Hypothesis: neoplasms in myotonic dystrophy.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Tumorigenesis is a multi-step process due to an accumulation of genetic mutations in multiple genes in diverse pathways which ultimately lead to loss of control over cell growth. It is well known that inheritance of rare germline mutations in genes involved in tumorigenesis pathways confer high
[Anesthetic managements of a patient with congenital myotonia (Becker type)].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
A 55-year-old woman with congenital myotonia (Becker type), diagnosed by muscle biopsy and gene examination, underwent a right lower lobectomy assisted with thoracoscopy for lung cancer. After epidural tube replacement at T 9-10, general anesthesia was introduced with propofol 2.5 mg x kg(-1) and
Oxaliplatin-induced hyperexcitability syndrome in a patient with pancreatic cancer.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
A recent pooled analysis and a meta-analysis suggested a survival benefit of gemcitabine-platinum doublets when compared with single agent gemcitabine in pancreatic cancer. Sensory neurotoxicity is a potentially limiting toxicity associated with oxaliplatin therapy. In this letter, we describe a
Diabetes, Metformin, and Cancer Risk in Myotonic Dystrophy Type I.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Myotonic dystrophy Type I (DM1) is an autosomal dominant multi-system disorder characterized by myotonia and muscle weakness. Type 2 diabetes (T2D) and cancer have been shown to be part of the DM1 phenotype. Metformin, a well-established agent for the management of T2D, is thought to have
Ganoderma sinense polysaccharide: An adjunctive drug used for cancer treatment.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Ganoderma sinense is one of well-known herb medicine and has been used for 2000 years in China. G. lucidum and G. sinense are two family members of Ganoderma, a genus of polypore fungi. In Chinese, "Lingzhi" is designated as G. lucidum or red "Lingzhi" whereas "Zizhi"
Phase II clinical trial of didemnin B in previously treated small cell lung cancer.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Didemnin B (NSC 325319), a cyclic depsipeptide isolated from a Carribean sea tunicate, exhibited potent antitumor activity in preclinical studies. After determining the maximum tolerated dose in our previous phase I/II trial, we conducted a phase II study of this drug in patients with previously
Long-Term Safety and Usefulness of Mexiletine in a Large Cohort of Patients Affected by Non-dystrophic Myotonias
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Objective: The aim of our study was to evaluate the long-term efficacy and safety of mexiletine in 112 patients affected by genetically confirmed non-dystrophic myotonias. The study was performed at the Neurophysiologic Division of Fondazione Policlinico Universitario A. Gemelli Istituto di
[Multiple basaliomas in Curschmann-Steinert myotonia atrophica].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The occurrence of multiple basal-cell epitheliomas in connection with myotonic dystrophy has not previously been reported. The possibility of myotonic dystrophy being a predisposing factor for different kinds of neoplasms is discussed.
[Multiple pigmented basalioma of the scalp in a patient with Curschmann-Steinert myotonia dystrophica. Confirmation of a rare symptom constellation].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
A 50-year-old woman presented with myotonic dystrophy (Curschmann-Steinert disease) and multiple pigmented basal cell carcinomas of the scalp. She also had typical androgenetic alopecia seen in this disorder. In 1986 Stieler and Plewig described the first patient with myotonic dystrophy and multiple
The human CDC42 gene: genomic organization, evidence for the existence of a putative pseudogene and exclusion as a SJS1 candidate gene.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Schwartz-Jampel syndrome (SJS) is an autosomal recessive human disorder characterized by myotonia and osteoarticular deformities. Three types are distinguished based on age at onset: types 1A, 1B and 2. We have previously localized the SJS1 gene, responsible for types 1A and 1B, on human chromosome
Basal cell carcinomas in a young woman with Steinert's disease.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Steinert's disease or Myotonic dystrophy type I (DM1) is an autosomal dominant disease characterized by myotonia, muscular dystrophy, cataracts, hypogonadism, frontal balding, and electrocardiographic alterations.Several tumors have been associated with DM1 such as pilomatricoma, thymomas and
[A genetic systemic disease: clinical description of type 1 myotonic dystrophy in adults].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Type 1 myotonic dystrophy is an autosomal dominant inherited disorder related to the expansion of a trinucleotide (CTG) repeat in the exon 15 in the 3'-untranslated region of the myotonic dystrophy protein kinase (DMPK) gene. Mutant transcripts containing an expanded CUG repeat are retained in
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
